BioNexus Gene Lab Corp Common stock Asset Resilience Ratio
BioNexus Gene Lab Corp Common stock asset resilience ratio. BioNexus Gene Lab Corp Common stock (BGLC) has an Asset Resilience Ratio of 22.85% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See BGLC cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of BioNexus Gene Lab Corp Common stock (2017–2024)
Asset resilience ratio of BioNexus Gene Lab Corp Common stock from 2017 to 2024. This chart shows how BioNexus Gene Lab Corp Common stock's Asset Resilience Ratio has changed over time. Read BioNexus Gene Lab Corp Common stock (BGLC) total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down BioNexus Gene Lab Corp Common stock's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see BioNexus Gene Lab Corp Common stock asset portfolio.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $1.74 Million | 22.85% |
| Total Liquid Assets | $1.74 Million | 22.85% |
Asset Resilience Insights
- Good Liquidity Position: BioNexus Gene Lab Corp Common stock maintains a healthy 22.85% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company has significant short-term investments, indicating active treasury management.
BioNexus Gene Lab Corp Common stock Industry Peers by Asset Resilience Ratio
Compare BioNexus Gene Lab Corp Common stock's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Hengyi Petrochemical Co Ltd
SHE:000703 |
Specialty Chemicals | 0.06% |
|
Akzo Nobel NV
AS:AKZA |
Specialty Chemicals | 2.16% |
|
LB Group Co Ltd
SHE:002601 |
Specialty Chemicals | 4.81% |
|
Suzhou TA&A Ultra Clean Technology Co Ltd
SHE:300390 |
Specialty Chemicals | 0.39% |
|
Cngr Advanced Material Co Ltd
SHE:300919 |
Specialty Chemicals | 0.52% |
|
Qingdao Gon Technology Co Ltd
SHE:002768 |
Specialty Chemicals | 0.01% |
|
Shenzhen Chengxin Lithium Group Co Ltd
SHE:002240 |
Specialty Chemicals | 0.00% |
|
Borregaard ASA
OL:BRG |
Specialty Chemicals | 0.98% |
BioNexus Gene Lab Corp Common stock Asset Resilience Ratio by Year (2017–2024)
BioNexus Gene Lab Corp Common stock asset resilience ratio by year from 2017 to 2024. The table below shows the annual Asset Resilience Ratio data for BioNexus Gene Lab Corp Common stock.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 26.78% | $2.79 Million | $10.43 Million | -2.22pp |
| 2023-12-31 | 29.00% | $3.31 Million | $11.40 Million | +11.75pp |
| 2022-12-31 | 17.24% | $1.51 Million | $8.74 Million | +1.10pp |
| 2021-12-31 | 16.14% | $1.55 Million | $9.57 Million | -4.50pp |
| 2020-12-31 | 20.64% | $2.09 Million | $10.12 Million | -19.40pp |
| 2019-12-31 | 40.04% | $493.04K | $1.23 Million | +3.67pp |
| 2018-12-31 | 36.38% | $601.00K | $1.65 Million | +36.18pp |
| 2017-12-31 | 0.20% | $2.55K | $1.27 Million | -- |
About BioNexus Gene Lab Corp Common stock
BioNexus Gene Lab Corp., through its subsidiaries, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company operates through three segments: Trading of Industrial Chemicals; Provision for Genomic Screening Services; a… Read more